Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems
Abstract Automated antimicrobial susceptibility testing devices are widely implemented in clinical microbiology laboratories in Spain, mainly using EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints. In 2007, a group of experts published recommendations for including ant...
Gespeichert in:
Veröffentlicht in: | Enfermedades infecciosas y microbiologia clinica 2020-04, Vol.38 (4), p.182-187 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 187 |
---|---|
container_issue | 4 |
container_start_page | 182 |
container_title | Enfermedades infecciosas y microbiologia clinica |
container_volume | 38 |
creator | Cantón, Rafael Oliver, Antonio Alós, Juan Ignacio de Benito, Natividad Bou, Germán Campos, José Calvo, Jorge Canut, Andrés Castillo, Javier Cercenado, Emilia Domínguez, Maria Ángeles Fernández-Cuenca, Felipe Guinea, Jesús Larrosa, Nieves Liñares, Josefina López-Cerero, Lorena López-Navas, Antonio Marco, Francesc Mirelis, Beatriz Moreno-Romo, Miguel Ángel Morosini, María Isabel Navarro, Ferran Oteo, Jesús Pascual, Álvaro Pérez-Trallero, Emilio Pérez-Vázquez, María Soriano, Alex Torres, Carmen Vila, Jordi Martínez-Martínez, Luis |
description | Abstract Automated antimicrobial susceptibility testing devices are widely implemented in clinical microbiology laboratories in Spain, mainly using EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints. In 2007, a group of experts published recommendations for including antimicrobial agents and selecting concentrations in these systems. Under the patronage of the Spanish Antibiogram Committee ( Comité Español del Antibiograma , COESANT) and the Study Group on Mechanisms of Action and Resistance to Antimicrobial Agents (GEMARA) from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), and aligned with the Spanish National Plan against Antimicrobial Resistance (PRAN), a group of experts have updated this document. The main modifications from the previous version comprise the inclusion of new antimicrobial agents, adaptation of the ranges of concentrations to cover the EUCAST breakpoints and epidemiological cut-off values (ECOFFs), and the inference of new resistance mechanisms. This proposal should be considered by different manufacturers and users when designing new panels or cards. In addition, recommendations for selective reporting are also included. With this approach, the implementation of EUCAST breakpoints will be easier, increasing the quality of antimicrobial susceptibility testing data and their microbiological interpretation. It will also benefit epidemiological surveillance studies as well as the clinical use of antimicrobials aligned with antimicrobial stewardship programs. |
doi_str_mv | 10.1016/j.eimc.2019.01.017 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2193602320</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0213005X19301351</els_id><sourcerecordid>2193602320</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-e55bc3395095c7e202ff0cefd2f545b61dea3d663abcb6ea9d1df4aa8a19fab03</originalsourceid><addsrcrecordid>eNp9UsuKFDEULURx2tEfcCFZjotq8-jUA0RomvEBgwP2CO5CKrnVk7YqaXNTA_1XfqIpu3XhQrgQEs45N_ecWxQvGV0yyqo3-yW40Sw5Ze2Sslz1o2LBZN2UrJH8cbGgnImSUvntoniGuKeUSyHE0-JC0KZuBBOL4ucXMGEcwVudXPBIQk_SPZDtQXuH92Ttk-tc2EU9kk0GupQAyNXm9nq7_nz3mvQhEoQBTHJ-R3RGj87E0Dk9EL0DnzA_WmKCN_kSz01mlvPkwaUYCE5o4DC3GVw6EkyTdYBkwt-KUwqjTmAJHjHBiM-LJ70eEF6cz8vi6_vru83H8ub2w6fN-qY0KylTCVJ2RohW0laaGjjlfU8N9Jb3ciW7ilnQwlaV0J3pKtCtZbZfad1o1va6o-KyuDrpHmL4MQEmNbr8z2HQHsKEirNWVJQLPkP5CZoHR4zQq0N0o45Hxaiak1J7NSel5qQUZbnqTHp11p-6Eexfyp9oMuDtCQB5ygcHUaFxkG20Lma7lQ3u__rv_qGbwXln9PAdjoD7MEWf_VNMIVdUbeddmVclj0WZkEz8Agiwv4M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2193602320</pqid></control><display><type>article</type><title>Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems</title><source>Elsevier ScienceDirect Journals Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Cantón, Rafael ; Oliver, Antonio ; Alós, Juan Ignacio ; de Benito, Natividad ; Bou, Germán ; Campos, José ; Calvo, Jorge ; Canut, Andrés ; Castillo, Javier ; Cercenado, Emilia ; Domínguez, Maria Ángeles ; Fernández-Cuenca, Felipe ; Guinea, Jesús ; Larrosa, Nieves ; Liñares, Josefina ; López-Cerero, Lorena ; López-Navas, Antonio ; Marco, Francesc ; Mirelis, Beatriz ; Moreno-Romo, Miguel Ángel ; Morosini, María Isabel ; Navarro, Ferran ; Oteo, Jesús ; Pascual, Álvaro ; Pérez-Trallero, Emilio ; Pérez-Vázquez, María ; Soriano, Alex ; Torres, Carmen ; Vila, Jordi ; Martínez-Martínez, Luis</creator><creatorcontrib>Cantón, Rafael ; Oliver, Antonio ; Alós, Juan Ignacio ; de Benito, Natividad ; Bou, Germán ; Campos, José ; Calvo, Jorge ; Canut, Andrés ; Castillo, Javier ; Cercenado, Emilia ; Domínguez, Maria Ángeles ; Fernández-Cuenca, Felipe ; Guinea, Jesús ; Larrosa, Nieves ; Liñares, Josefina ; López-Cerero, Lorena ; López-Navas, Antonio ; Marco, Francesc ; Mirelis, Beatriz ; Moreno-Romo, Miguel Ángel ; Morosini, María Isabel ; Navarro, Ferran ; Oteo, Jesús ; Pascual, Álvaro ; Pérez-Trallero, Emilio ; Pérez-Vázquez, María ; Soriano, Alex ; Torres, Carmen ; Vila, Jordi ; Martínez-Martínez, Luis</creatorcontrib><description>Abstract Automated antimicrobial susceptibility testing devices are widely implemented in clinical microbiology laboratories in Spain, mainly using EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints. In 2007, a group of experts published recommendations for including antimicrobial agents and selecting concentrations in these systems. Under the patronage of the Spanish Antibiogram Committee ( Comité Español del Antibiograma , COESANT) and the Study Group on Mechanisms of Action and Resistance to Antimicrobial Agents (GEMARA) from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), and aligned with the Spanish National Plan against Antimicrobial Resistance (PRAN), a group of experts have updated this document. The main modifications from the previous version comprise the inclusion of new antimicrobial agents, adaptation of the ranges of concentrations to cover the EUCAST breakpoints and epidemiological cut-off values (ECOFFs), and the inference of new resistance mechanisms. This proposal should be considered by different manufacturers and users when designing new panels or cards. In addition, recommendations for selective reporting are also included. With this approach, the implementation of EUCAST breakpoints will be easier, increasing the quality of antimicrobial susceptibility testing data and their microbiological interpretation. It will also benefit epidemiological surveillance studies as well as the clinical use of antimicrobials aligned with antimicrobial stewardship programs.</description><identifier>ISSN: 0213-005X</identifier><identifier>EISSN: 1578-1852</identifier><identifier>EISSN: 2529-993X</identifier><identifier>DOI: 10.1016/j.eimc.2019.01.017</identifier><identifier>PMID: 30878313</identifier><language>eng</language><publisher>Spain: Elsevier España, S.L.U</publisher><subject>Antibiogram ; Antibiograma ; Automated susceptibility testing systems ; CMI ; Concentraciones mínimas antimicrobianas ; Infectious Disease ; MICs ; Minimum antimicrobial concentrations ; Sistemas automáticos de detección de sensibilidad</subject><ispartof>Enfermedades infecciosas y microbiologia clinica, 2020-04, Vol.38 (4), p.182-187</ispartof><rights>Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica</rights><rights>2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica</rights><rights>Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-e55bc3395095c7e202ff0cefd2f545b61dea3d663abcb6ea9d1df4aa8a19fab03</citedby><cites>FETCH-LOGICAL-c455t-e55bc3395095c7e202ff0cefd2f545b61dea3d663abcb6ea9d1df4aa8a19fab03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0213005X19301351$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30878313$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cantón, Rafael</creatorcontrib><creatorcontrib>Oliver, Antonio</creatorcontrib><creatorcontrib>Alós, Juan Ignacio</creatorcontrib><creatorcontrib>de Benito, Natividad</creatorcontrib><creatorcontrib>Bou, Germán</creatorcontrib><creatorcontrib>Campos, José</creatorcontrib><creatorcontrib>Calvo, Jorge</creatorcontrib><creatorcontrib>Canut, Andrés</creatorcontrib><creatorcontrib>Castillo, Javier</creatorcontrib><creatorcontrib>Cercenado, Emilia</creatorcontrib><creatorcontrib>Domínguez, Maria Ángeles</creatorcontrib><creatorcontrib>Fernández-Cuenca, Felipe</creatorcontrib><creatorcontrib>Guinea, Jesús</creatorcontrib><creatorcontrib>Larrosa, Nieves</creatorcontrib><creatorcontrib>Liñares, Josefina</creatorcontrib><creatorcontrib>López-Cerero, Lorena</creatorcontrib><creatorcontrib>López-Navas, Antonio</creatorcontrib><creatorcontrib>Marco, Francesc</creatorcontrib><creatorcontrib>Mirelis, Beatriz</creatorcontrib><creatorcontrib>Moreno-Romo, Miguel Ángel</creatorcontrib><creatorcontrib>Morosini, María Isabel</creatorcontrib><creatorcontrib>Navarro, Ferran</creatorcontrib><creatorcontrib>Oteo, Jesús</creatorcontrib><creatorcontrib>Pascual, Álvaro</creatorcontrib><creatorcontrib>Pérez-Trallero, Emilio</creatorcontrib><creatorcontrib>Pérez-Vázquez, María</creatorcontrib><creatorcontrib>Soriano, Alex</creatorcontrib><creatorcontrib>Torres, Carmen</creatorcontrib><creatorcontrib>Vila, Jordi</creatorcontrib><creatorcontrib>Martínez-Martínez, Luis</creatorcontrib><title>Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems</title><title>Enfermedades infecciosas y microbiologia clinica</title><addtitle>Enferm Infecc Microbiol Clin</addtitle><description>Abstract Automated antimicrobial susceptibility testing devices are widely implemented in clinical microbiology laboratories in Spain, mainly using EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints. In 2007, a group of experts published recommendations for including antimicrobial agents and selecting concentrations in these systems. Under the patronage of the Spanish Antibiogram Committee ( Comité Español del Antibiograma , COESANT) and the Study Group on Mechanisms of Action and Resistance to Antimicrobial Agents (GEMARA) from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), and aligned with the Spanish National Plan against Antimicrobial Resistance (PRAN), a group of experts have updated this document. The main modifications from the previous version comprise the inclusion of new antimicrobial agents, adaptation of the ranges of concentrations to cover the EUCAST breakpoints and epidemiological cut-off values (ECOFFs), and the inference of new resistance mechanisms. This proposal should be considered by different manufacturers and users when designing new panels or cards. In addition, recommendations for selective reporting are also included. With this approach, the implementation of EUCAST breakpoints will be easier, increasing the quality of antimicrobial susceptibility testing data and their microbiological interpretation. It will also benefit epidemiological surveillance studies as well as the clinical use of antimicrobials aligned with antimicrobial stewardship programs.</description><subject>Antibiogram</subject><subject>Antibiograma</subject><subject>Automated susceptibility testing systems</subject><subject>CMI</subject><subject>Concentraciones mínimas antimicrobianas</subject><subject>Infectious Disease</subject><subject>MICs</subject><subject>Minimum antimicrobial concentrations</subject><subject>Sistemas automáticos de detección de sensibilidad</subject><issn>0213-005X</issn><issn>1578-1852</issn><issn>2529-993X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9UsuKFDEULURx2tEfcCFZjotq8-jUA0RomvEBgwP2CO5CKrnVk7YqaXNTA_1XfqIpu3XhQrgQEs45N_ecWxQvGV0yyqo3-yW40Sw5Ze2Sslz1o2LBZN2UrJH8cbGgnImSUvntoniGuKeUSyHE0-JC0KZuBBOL4ucXMGEcwVudXPBIQk_SPZDtQXuH92Ttk-tc2EU9kk0GupQAyNXm9nq7_nz3mvQhEoQBTHJ-R3RGj87E0Dk9EL0DnzA_WmKCN_kSz01mlvPkwaUYCE5o4DC3GVw6EkyTdYBkwt-KUwqjTmAJHjHBiM-LJ70eEF6cz8vi6_vru83H8ub2w6fN-qY0KylTCVJ2RohW0laaGjjlfU8N9Jb3ciW7ilnQwlaV0J3pKtCtZbZfad1o1va6o-KyuDrpHmL4MQEmNbr8z2HQHsKEirNWVJQLPkP5CZoHR4zQq0N0o45Hxaiak1J7NSel5qQUZbnqTHp11p-6Eexfyp9oMuDtCQB5ygcHUaFxkG20Lma7lQ3u__rv_qGbwXln9PAdjoD7MEWf_VNMIVdUbeddmVclj0WZkEz8Agiwv4M</recordid><startdate>20200401</startdate><enddate>20200401</enddate><creator>Cantón, Rafael</creator><creator>Oliver, Antonio</creator><creator>Alós, Juan Ignacio</creator><creator>de Benito, Natividad</creator><creator>Bou, Germán</creator><creator>Campos, José</creator><creator>Calvo, Jorge</creator><creator>Canut, Andrés</creator><creator>Castillo, Javier</creator><creator>Cercenado, Emilia</creator><creator>Domínguez, Maria Ángeles</creator><creator>Fernández-Cuenca, Felipe</creator><creator>Guinea, Jesús</creator><creator>Larrosa, Nieves</creator><creator>Liñares, Josefina</creator><creator>López-Cerero, Lorena</creator><creator>López-Navas, Antonio</creator><creator>Marco, Francesc</creator><creator>Mirelis, Beatriz</creator><creator>Moreno-Romo, Miguel Ángel</creator><creator>Morosini, María Isabel</creator><creator>Navarro, Ferran</creator><creator>Oteo, Jesús</creator><creator>Pascual, Álvaro</creator><creator>Pérez-Trallero, Emilio</creator><creator>Pérez-Vázquez, María</creator><creator>Soriano, Alex</creator><creator>Torres, Carmen</creator><creator>Vila, Jordi</creator><creator>Martínez-Martínez, Luis</creator><general>Elsevier España, S.L.U</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200401</creationdate><title>Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems</title><author>Cantón, Rafael ; Oliver, Antonio ; Alós, Juan Ignacio ; de Benito, Natividad ; Bou, Germán ; Campos, José ; Calvo, Jorge ; Canut, Andrés ; Castillo, Javier ; Cercenado, Emilia ; Domínguez, Maria Ángeles ; Fernández-Cuenca, Felipe ; Guinea, Jesús ; Larrosa, Nieves ; Liñares, Josefina ; López-Cerero, Lorena ; López-Navas, Antonio ; Marco, Francesc ; Mirelis, Beatriz ; Moreno-Romo, Miguel Ángel ; Morosini, María Isabel ; Navarro, Ferran ; Oteo, Jesús ; Pascual, Álvaro ; Pérez-Trallero, Emilio ; Pérez-Vázquez, María ; Soriano, Alex ; Torres, Carmen ; Vila, Jordi ; Martínez-Martínez, Luis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-e55bc3395095c7e202ff0cefd2f545b61dea3d663abcb6ea9d1df4aa8a19fab03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibiogram</topic><topic>Antibiograma</topic><topic>Automated susceptibility testing systems</topic><topic>CMI</topic><topic>Concentraciones mínimas antimicrobianas</topic><topic>Infectious Disease</topic><topic>MICs</topic><topic>Minimum antimicrobial concentrations</topic><topic>Sistemas automáticos de detección de sensibilidad</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cantón, Rafael</creatorcontrib><creatorcontrib>Oliver, Antonio</creatorcontrib><creatorcontrib>Alós, Juan Ignacio</creatorcontrib><creatorcontrib>de Benito, Natividad</creatorcontrib><creatorcontrib>Bou, Germán</creatorcontrib><creatorcontrib>Campos, José</creatorcontrib><creatorcontrib>Calvo, Jorge</creatorcontrib><creatorcontrib>Canut, Andrés</creatorcontrib><creatorcontrib>Castillo, Javier</creatorcontrib><creatorcontrib>Cercenado, Emilia</creatorcontrib><creatorcontrib>Domínguez, Maria Ángeles</creatorcontrib><creatorcontrib>Fernández-Cuenca, Felipe</creatorcontrib><creatorcontrib>Guinea, Jesús</creatorcontrib><creatorcontrib>Larrosa, Nieves</creatorcontrib><creatorcontrib>Liñares, Josefina</creatorcontrib><creatorcontrib>López-Cerero, Lorena</creatorcontrib><creatorcontrib>López-Navas, Antonio</creatorcontrib><creatorcontrib>Marco, Francesc</creatorcontrib><creatorcontrib>Mirelis, Beatriz</creatorcontrib><creatorcontrib>Moreno-Romo, Miguel Ángel</creatorcontrib><creatorcontrib>Morosini, María Isabel</creatorcontrib><creatorcontrib>Navarro, Ferran</creatorcontrib><creatorcontrib>Oteo, Jesús</creatorcontrib><creatorcontrib>Pascual, Álvaro</creatorcontrib><creatorcontrib>Pérez-Trallero, Emilio</creatorcontrib><creatorcontrib>Pérez-Vázquez, María</creatorcontrib><creatorcontrib>Soriano, Alex</creatorcontrib><creatorcontrib>Torres, Carmen</creatorcontrib><creatorcontrib>Vila, Jordi</creatorcontrib><creatorcontrib>Martínez-Martínez, Luis</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Enfermedades infecciosas y microbiologia clinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cantón, Rafael</au><au>Oliver, Antonio</au><au>Alós, Juan Ignacio</au><au>de Benito, Natividad</au><au>Bou, Germán</au><au>Campos, José</au><au>Calvo, Jorge</au><au>Canut, Andrés</au><au>Castillo, Javier</au><au>Cercenado, Emilia</au><au>Domínguez, Maria Ángeles</au><au>Fernández-Cuenca, Felipe</au><au>Guinea, Jesús</au><au>Larrosa, Nieves</au><au>Liñares, Josefina</au><au>López-Cerero, Lorena</au><au>López-Navas, Antonio</au><au>Marco, Francesc</au><au>Mirelis, Beatriz</au><au>Moreno-Romo, Miguel Ángel</au><au>Morosini, María Isabel</au><au>Navarro, Ferran</au><au>Oteo, Jesús</au><au>Pascual, Álvaro</au><au>Pérez-Trallero, Emilio</au><au>Pérez-Vázquez, María</au><au>Soriano, Alex</au><au>Torres, Carmen</au><au>Vila, Jordi</au><au>Martínez-Martínez, Luis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems</atitle><jtitle>Enfermedades infecciosas y microbiologia clinica</jtitle><addtitle>Enferm Infecc Microbiol Clin</addtitle><date>2020-04-01</date><risdate>2020</risdate><volume>38</volume><issue>4</issue><spage>182</spage><epage>187</epage><pages>182-187</pages><issn>0213-005X</issn><eissn>1578-1852</eissn><eissn>2529-993X</eissn><abstract>Abstract Automated antimicrobial susceptibility testing devices are widely implemented in clinical microbiology laboratories in Spain, mainly using EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints. In 2007, a group of experts published recommendations for including antimicrobial agents and selecting concentrations in these systems. Under the patronage of the Spanish Antibiogram Committee ( Comité Español del Antibiograma , COESANT) and the Study Group on Mechanisms of Action and Resistance to Antimicrobial Agents (GEMARA) from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), and aligned with the Spanish National Plan against Antimicrobial Resistance (PRAN), a group of experts have updated this document. The main modifications from the previous version comprise the inclusion of new antimicrobial agents, adaptation of the ranges of concentrations to cover the EUCAST breakpoints and epidemiological cut-off values (ECOFFs), and the inference of new resistance mechanisms. This proposal should be considered by different manufacturers and users when designing new panels or cards. In addition, recommendations for selective reporting are also included. With this approach, the implementation of EUCAST breakpoints will be easier, increasing the quality of antimicrobial susceptibility testing data and their microbiological interpretation. It will also benefit epidemiological surveillance studies as well as the clinical use of antimicrobials aligned with antimicrobial stewardship programs.</abstract><cop>Spain</cop><pub>Elsevier España, S.L.U</pub><pmid>30878313</pmid><doi>10.1016/j.eimc.2019.01.017</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0213-005X |
ispartof | Enfermedades infecciosas y microbiologia clinica, 2020-04, Vol.38 (4), p.182-187 |
issn | 0213-005X 1578-1852 2529-993X |
language | eng |
recordid | cdi_proquest_miscellaneous_2193602320 |
source | Elsevier ScienceDirect Journals Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Antibiogram Antibiograma Automated susceptibility testing systems CMI Concentraciones mínimas antimicrobianas Infectious Disease MICs Minimum antimicrobial concentrations Sistemas automáticos de detección de sensibilidad |
title | Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T21%3A38%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommendations%20of%20the%20Spanish%20Antibiogram%20Committee%20(COESANT)%20for%20selecting%20antimicrobial%20agents%20and%20concentrations%20for%20in%20vitro%20susceptibility%20studies%20using%20automated%20systems&rft.jtitle=Enfermedades%20infecciosas%20y%20microbiologia%20clinica&rft.au=Cant%C3%B3n,%20Rafael&rft.date=2020-04-01&rft.volume=38&rft.issue=4&rft.spage=182&rft.epage=187&rft.pages=182-187&rft.issn=0213-005X&rft.eissn=1578-1852&rft_id=info:doi/10.1016/j.eimc.2019.01.017&rft_dat=%3Cproquest_cross%3E2193602320%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2193602320&rft_id=info:pmid/30878313&rft_els_id=1_s2_0_S0213005X19301351&rfr_iscdi=true |